Abstract
The goal of oncolytic therapy is to exploit the innate ability of viruses to infect tumor cells, replicate in tumor cells, and produce selective oncolysis while sparing normal cells. Although the concept that viruses can be oncolytic is not new, it is only in the last three decades that efforts have been directed at genetically mutating viruses to specifically target characteristics of cancer cells. Several viruses have the potential to infect, replicate and lyse tumor cells, each taking advantage of different host cancer cell biology. This review will focus on the major viruses under current investigation for oncolytic therapy, the mechanism by which they specifically eradicate tumors, and the clinical strategies currently under investigation.
Keywords: oncolytic viral therapy, suicide gene, hsv, adenovirus, vaccinia, reovirus, parvovirus, Vesicular stomatitis virus, newcastle virus, dlsptk
Current Molecular Medicine
Title: Novel Approaches to Cancer Therapy Using Oncolytic Viruses
Volume: 3 Issue: 1
Author(s): S. F. Stanziale and Y. Fong
Affiliation:
Keywords: oncolytic viral therapy, suicide gene, hsv, adenovirus, vaccinia, reovirus, parvovirus, Vesicular stomatitis virus, newcastle virus, dlsptk
Abstract: The goal of oncolytic therapy is to exploit the innate ability of viruses to infect tumor cells, replicate in tumor cells, and produce selective oncolysis while sparing normal cells. Although the concept that viruses can be oncolytic is not new, it is only in the last three decades that efforts have been directed at genetically mutating viruses to specifically target characteristics of cancer cells. Several viruses have the potential to infect, replicate and lyse tumor cells, each taking advantage of different host cancer cell biology. This review will focus on the major viruses under current investigation for oncolytic therapy, the mechanism by which they specifically eradicate tumors, and the clinical strategies currently under investigation.
Export Options
About this article
Cite this article as:
Stanziale F. S. and Fong Y., Novel Approaches to Cancer Therapy Using Oncolytic Viruses, Current Molecular Medicine 2003; 3 (1) . https://dx.doi.org/10.2174/1566524033361663
DOI https://dx.doi.org/10.2174/1566524033361663 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Berberine as a Promising Safe Anti-Cancer Agent- Is there a Role for Mitochondria?
Current Drug Targets Mechanisms of Tumor Cell Necrosis
Current Pharmaceutical Design Anti-Cancer Drug Design Using Natural and Synthetic Pharmacophores
Current Organic Chemistry Recent Developments in the Field of Tumor-Inhibiting Metal Complexes
Current Pharmaceutical Design Castration Resistant Prostate Cancer: From Emerging Molecular Pathways to Targeted Therapeutic Approaches
Clinical Cancer Drugs Inflammation and Antiangiogenesis in Cancer
Current Medicinal Chemistry Implication of Nanofibers in Oral Drug Delivery
Current Pharmaceutical Design Protein-Based Voltammetric Biosensors Fabricated with Nanomaterials
Protein & Peptide Letters Effective Prodrug Liposome and Conversion to Active Metabolite
Current Drug Metabolism Synthesis and Preliminary Cytotoxicity Studies of 1-[1-(4,5-Dihydrooxazol- 2-yl)-1H-indazol-3-yl]-3-phenylurea and 3-phenylthiourea Derivatives
Medicinal Chemistry The Synthesis, Structure and Activity Evaluation of Secnidazole Derivatives as Helicobacter pylori Urease Inhibitors
Current Bioactive Compounds Pharmacological Activity of Natural Non-glycosylated Triterpenes
Mini-Reviews in Organic Chemistry Patent Analysis as a Tool for Research Planning: Study on Natural Based Therapeutics Against Cancer Stem Cells
Recent Patents on Anti-Cancer Drug Discovery Regulatory T Cells: Major Players in the Tumor Microenvironment
Current Pharmaceutical Design Pore-forming Peptides: A New Treatment Option for Cancer
Current Medicinal Chemistry Chebulagic Acid Synergizes the Cytotoxicity of Doxorubicin in Human Hepatocellular Carcinoma Through COX-2 Dependant Modulation of MDR-1
Medicinal Chemistry Pharmacology of Rhein and Advancement in the Synthesis of Its Derivatives
Current Traditional Medicine Mitochondrial Drug Targets in Cell Death and Cancer
Current Pharmaceutical Design Dimer and Tetramer of Gallic Acid: Facile Synthesis, Antioxidant and Antiproliferative Activities
Letters in Drug Design & Discovery The Ubiquitin-Proteasome System (UPS) and the Mechanism of Action of Bortezomib
Current Pharmaceutical Design